Table 5.
Univariate linear regression analysis between triglyceride-glucose index (TyG) index and risk factors
| β (95% CI) | P-value | |
|---|---|---|
| Age, years | 0.001 (− 0.001 to 0.004) | 0.333 |
| Sex, male | 0.224 (0.181 to 0.266) | < 0.001 |
| Body mass index, kg/m2 | 0.058 (0.051 to 0.064) | < 0.001 |
| Use of antihypertensives | 0.134 (0.077 to 0.190) | < 0.001 |
| Use of antiplatelet agents | 0.064 (− 0.016 to 0.143) | 0.119 |
| Systolic blood pressure, mmHg | 0.009 (0.007 to 0.010) | < 0.001 |
| Diastolic blood pressure, mmHg | 0.012 (0.010 to 0.014) | < 0.001 |
| Hemoglobin A1c, %* | 2.004 (1.799 to 2.208) | < 0.001 |
| Fasting glucose, mg/dL* | 1.833 (1.727 to 1.939) | < 0.001 |
| Insulin, µU/mL* | 0.358 (0.324 to 0.391) | < 0.001 |
| HOMA-IR* | 0.396 (0.367 to 0.426) | < 0.001 |
| Total cholesterol, mg/dL | 0.003 (0.002 to 0.003) | < 0.001 |
| LDL cholesterol, mg/dL | 0.001 (0.000 to 0.002) | 0.020 |
| HDL cholesterol, mg/dL | − 0.017 (− 0.019 to − 0.016) | < 0.001 |
| Triglyceride, mg/dL* | 1.100 (1.087 to 1.112) | < 0.001 |
| White blood cell counts, × 103/μL | 0.095 (0.083 to 0.108) | < 0.001 |
| hs-CRP, mg/dL* | 0.047 (0.032 to 0.061) | < 0.001 |
HOMA-IR: Homeostatic Model Assessment for Insulin Resistance; LDL: low-density lipoprotein; HDL: high-density lipoprotein; hs-CRP: high-sensitivity C-reactive protein
*These variables were transformed into a log scale